Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,565,774
+$139,132 QoQ
Shares Held
689,981
-5.4% QoQ
Ownership
0.316%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#61
of 652 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $848,593,086 across 183 Biotechnology names. INSM ranks #2 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
This page
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
622,603 | $34,205,808 |
All Filings in INSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,565,774 | 689,981 | Shares | Defined | 2026-08-14 | |
| 2025-06-30 | $73,426,642 | 729,597 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $676,730 | 24,944 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,307,717 | 106,735 | Shares | Defined | 2024-02-09 | |
| 2023-06-30 | $306,393 | 14,521 | Shares | Defined | 2023-08-11 | |
| 2022-09-30 | $731,175 | 33,945 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,045,376 | 53,011 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $250,604 | 10,664 | Shares | Defined | 2022-05-16 | |
| 2020-09-30 | $1,222,477 | 38,036 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||